Nervgen PharmaNGEN 13F holders, Q1 2026 (March 31) 45 holders +44
44 new positions
0 sold out
$3.79 avg. 13F price*
At the end of Q1 2026 , 45 institutions reported holding Nervgen Pharma Corp. (NGEN) in their 13F filings, up 44 from Q4 2025. 44 opened new positions and 0 sold out. The largest holders were PFG Investments, LLC ($758K), Bank of America Corp. ($756K) and Marshall Wace, LLP ($755K).
Company Nervgen Pharma Corp.
CUSIP 64082X203
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026 Institutions Total Value New Positions 44 $6.4M Exits 0 $0
All 13F filers, Q4 2025 → Q1 2026: 1,683,343 shares bought, net +1,683,343 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders Portfolio Manager % of Holder's Portfolio Change vs Q4 2025 Shares Value ▼ PFG Investments, LLC 0.04% New 201,000 $758K Bank of America Corp. 0.00% New 200,656 $756K Marshall Wace, LLP 0.00% New 200,359 $755K Royal Bank of Canada 0.00% New 171,961 $648K Integrated Wealth Concepts LLC 0.00% New 86,815 $327K Valley Forge Investment Consultants Inc. Adv 0.09% New 77,698 $293K Bank of Montreal 0.00% New 62,900 $237K Captrust Financial Advisors 0.00% New 62,367 $235K UBS Group AG 0.00% New 61,517 $232K Osaic Holdings, Inc. 0.00% New 39,991 $151K Patriot Financial Group Insurance Agency, LLC 0.01% New 37,000 $139K Commonwealth Equity Services, LLC 0.00% New 33,350 $126K Cetera Investment Advisers 0.00% New 31,400 $118K McKinley Carter Wealth Services, Inc. 0.01% New 30,892 $116K TD Waterhouse Canada Inc. 0.00% New 23,800 $103K Traynor Capital Management, Inc. 0.01% New 25,500 $95K Sprott Inc. 0.00% New 25,000 $94K Busey Bank 0.00% New 25,000 $94K Liberty Wealth Management LLC 0.01% New 22,000 $83K HRT Financial LP 0.00% New 21,366 $80K Great Valley Advisor Group, Inc. 0.00% New 21,000 $79K Almanack Investment Partners, LLC. 0.01% New 20,925 $79K JPMorgan Chase & Co. 0.00% New 13,462 $79K Envestnet Asset Management Inc. 0.00% New 20,000 $75K Arax Advisory Partners 0.00% New 18,028 $68K Mariner, LLC 0.00% New 17,875 $67K T. Rowe Price Associates Inc. 0.00% New 15,504 $59K LPL Financial LLC 0.00% New 13,400 $51K Scotia Capital Inc. 0.00% New 12,998 $49K Creative Planning 0.00% New 12,937 $49K Morgan Stanley 0.00% New 11,982 $45K Ashton Thomas Private Wealth, LLC 0.00% New 10,700 $40K Cibc World Market Inc. 0.00% New 10,560 $40K Flputnam Investment Management Co. 0.00% New 10,200 $38K Paladin Partners, LLC 0.03% No change 10,000 $38K D'Orazio & Associates, Inc. 0.00% New 10,000 $38K Aventura Private Wealth, LLC 0.01% New 6,880 $26K Allworth Financial LP 0.00% New 6,000 $23K Steward Partners Investment Advisory, LLC 0.00% New 4,103 $15K Smartleaf Asset Management LLC 0.00% New 3,656 $14K Jones Financial Companies LLLP 0.00% New 1,000 $4K National Bank of Canada 0.00% New 833 $3K MAI Capital Management 0.00% New 700 $3K Simplex Trading, LLC 0.00% New 27 $101 Caitong International Asset Management Co., Ltd 0.00% New 1 $4
"% of holder's portfolio" is NGEN's weight in each manager's 13F, not the share of Nervgen Pharma Corp. the manager owns.